0.9255

0.46% -0.0043

After Hours: .9197 -0.0058 -0.63%

Enveric Biosciences Inc (ENVB)

Overview News Price History Financials Discussions Forecast Stock Split Dividend History

Enveric Biosciences Inc stock is currently priced at $0.9255, with a 24-hour trading volume of 144.88K. It has seen a -0.46% decreased in the last 24 hours and a -18.82% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $0.9286 pivot point. If it approaches the $0.9022 support level, significant changes may occur.

Previous Close:

$0.9298

Open:

$0.94

24h Volume:

144.88K

Market Cap:

$6.75M

Revenue:

Net Income/Loss:

$-22.57M

P/E Ratio:

-0.0791

EPS:

-11.7

Net Cash Flow:

$-15.82M

1W Performance:

+2.83%

1M Performance:

-18.82%

6M Performance:

-50.77%

1Y Performance:

-49.40%

1D Range:

$0.905

$0.9549

52W Range:

$0.649

$6.98

Enveric Biosciences Inc Stock (ENVB) Company Profile

Name

Enveric Biosciences Inc

Sector

Healthcare (1190)

Industry

Biotechnology (681)

Phone

239 302 1707

Address

4851 Tamiami Trail N, Suite 200, Naples

Employee

Twitter

Next Earnings Date

2024-05-28

Latest SEC Filings

ENVB's Discussions on Twitter

Enveric Biosciences Inc Stock (ENVB) Latest News

Enveric Biosciences, Inc. (ENVB) Stock Falls Amid Market Uptick: What Investors Need to Know

Zacks Investment Research

Enveric Biosciences, Inc. (ENVB) Stock Declines While Market Improves: Some Information for Investors

Zacks Investment Research

Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga

Enveric Biosciences Inc Stock (ENVB) Financials Data

Enveric Biosciences Inc (ENVB) Net Income 2024

ENVB net income (TTM) was -$22.57 million for the quarter ending September 30, 2023, a +56.54% increase year-over-year.

Enveric Biosciences Inc (ENVB) Cash Flow 2024

ENVB recorded a free cash flow (TTM) of -$15.82 million for the quarter ending September 30, 2023, a +14.59% increase year-over-year.

Enveric Biosciences Inc (ENVB) Earnings per Share 2024

ENVB earnings per share (TTM) was -$11.54 for the quarter ending September 30, 2023, a +88.05% growth year-over-year.

Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. It has created a portfolio of new chemical entities for specific mental health indications using The Psybrary, a discovery and development platform. The company's lead program is the EVM201 series that comprise next generation synthetic psilocybin analogues that are considered prodrugs of the active metabolite psilocin. It is also advancing its third generation of therapeutics, the EVM301 Series, for treating central nervous system disorders. The company is headquartered in Naples, Florida with offices in Cambridge, Massachusetts and Calgary, Canada.